Wells Fargo & Company »

Aldeyra Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 345k 3.51
2023-09-30 $2.3M 343k 6.68
2023-06-30 $2.9M 340k 8.39
2022-12-31 $2.2M 318k 6.96
2022-09-30 $2.0M 310k 6.37
2022-06-30 $1.3M 331k 3.99
2022-03-31 $1.5M 331k 4.47
2021-12-31 $951k 237k 4.02
2021-09-30 $2.3M 260k 8.78
2021-06-30 $1.6M 141k 11.33
2021-03-31 $887k 75k 11.88
2020-12-31 $57k 7.3k 7.91
2020-09-30 $2.0k 237 8.44
2020-06-30 $1.6k 515 3.03
2020-03-31 $41k 17k 2.45
2019-12-31 $103k 18k 5.79
2019-09-30 $255k 49k 5.25
2019-06-30 $257k 43k 6.01
2019-03-31 $383k 42k 9.04
2018-12-31 $371k 45k 8.27
2018-09-30 $243k 18k 13.85
2018-06-30 $133k 17k 7.91
2018-03-31 $108k 15k 7.41
2017-12-31 $93k 14k 6.87